Marvyn T. Koning

MuSK myasthenia gravis monoclonal antibodies

Maartje G. Huijbers, Dana L.E. Vergoossen, Yvonne E. Fillié‐Grijpma et al. · Neurology Neuroimmunology & Neuroinflammation · 2019 · 97 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

<i> IGLV3-21 <i>*</i> 01 </i> is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling

Palash Chandra Maity, Mayas Bilal, Marvyn T. Koning et al. · Proceedings of the National Academy of Sciences · 2020 · 86 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

N-Glycosylation Site Analysis of Citrullinated Antigen-Specific B-Cell Receptors Indicates Alternative Selection Pathways During Autoreactive B-Cell Development

Rochelle D. Vergroesen, Linda M. Slot, Barbera D. C. van Schaik et al. · Frontiers in Immunology · 2019 · 37 citations · Full text

Life Sciences, Immunology, Pathobiology +17

A case of fulminant Epstein-Barr virus encephalitis in an immune-competent adult

Marvyn T. Koning, Tessa Brik, Rogier E. Hagenbeek et al. · Journal of NeuroVirology · 2019 · 22 citations

Life Sciences, Immunology, Neurology +13

Acquired N-Linked Glycosylation Motifs in B-Cell Receptors of Primary Cutaneous B-Cell Lymphoma and the Normal B-Cell Repertoire

Marvyn T. Koning, Edwin Quinten, Willem H. Zoutman et al. · Journal of Investigative Dermatology · 2019 · 18 citations · Full text

Life Sciences, Immunology, Oncology +17